These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27137931)

  • 41. High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis.
    Ogino W; Takeshima Y; Mori T; Yanai T; Hayakawa A; Akisue T; Kurosaka M; Matsuo M
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):435-9. PubMed ID: 17609619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
    Qin Y; Ye J; Zhao F; Hu S; Wang S
    Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Ezrin and Heat Shock Protein 70 on Apoptosis and Proliferation of Human Osteosarcoma Cells.
    Yao Q; Zhao HY; Xie BZ
    Orthop Surg; 2015 Aug; 7(3):273-80. PubMed ID: 26311104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osmotic cell shrinkage activates ezrin/radixin/moesin (ERM) proteins: activation mechanisms and physiological implications.
    Rasmussen M; Alexander RT; Darborg BV; Møbjerg N; Hoffmann EK; Kapus A; Pedersen SF
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C197-212. PubMed ID: 17977945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway.
    Hou CH; Lin FL; Tong KB; Hou SM; Liu JF
    Biochem Pharmacol; 2014 Jun; 89(4):453-63. PubMed ID: 24685520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
    Wan X; Mendoza A; Khanna C; Helman LJ
    Cancer Res; 2005 Mar; 65(6):2406-11. PubMed ID: 15781656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-tumor necrosis factor therapy inhibits lung metastasis in an osteosarcoma cell line.
    Kato H; Wakabayashi H; Naito Y; Kato S; Nakagawa T; Matsumine A; Sudo A
    Oncology; 2015; 88(3):139-46. PubMed ID: 25402182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
    Wang Z; He ML; Zhao JM; Qing HH; Wu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
    Hughes DP
    Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radixin knockdown by RNA interference suppresses human glioblastoma cell growth in vitro and in vivo.
    Qin JJ; Wang JM; Du J; Zeng C; Han W; Li ZD; Xie J; Li GL
    Asian Pac J Cancer Prev; 2014; 15(22):9805-12. PubMed ID: 25520109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimetastatic activity of honokiol in osteosarcoma.
    Steinmann P; Walters DK; Arlt MJ; Banke IJ; Ziegler U; Langsam B; Arbiser J; Muff R; Born W; Fuchs B
    Cancer; 2012 Apr; 118(8):2117-27. PubMed ID: 21935912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacologic Inhibition of Ezrin-Radixin-Moesin Phosphorylation is a Novel Therapeutic Strategy in Rhabdomyosarcoma.
    Proudfit A; Bhunia N; Pore D; Parker Y; Lindner D; Gupta N
    Sarcoma; 2020; 2020():9010496. PubMed ID: 33005093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma.
    Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of Ezrin correlates with lung metastasis in Chinese patients with osteosarcoma.
    Xu-Dong S; Zan S; Shui-er Z; Li-na T; Wen-xi Y; Feng L; Yang Y
    Clin Invest Med; 2009 Apr; 32(2):E180-8. PubMed ID: 19331807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin.
    Kaya M; Wada T; Nagoya S; Yamashita T
    J Orthop Sci; 2007 Nov; 12(6):562-7. PubMed ID: 18040639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo.
    Comstock KE; Hall CL; Daignault S; Mandlebaum SA; Yu C; Keller ET
    In Vivo; 2009; 23(5):661-8. PubMed ID: 19779098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
    Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
    Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
    Wang G; Sun M; Jiang Y; Zhang T; Sun W; Wang H; Yin F; Wang Z; Sang W; Xu J; Mao M; Zuo D; Zhou Z; Wang C; Fu Z; Wang Z; Duan Z; Hua Y; Cai Z
    Int J Cancer; 2019 Aug; 145(4):979-993. PubMed ID: 30719715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.